MedPath

Taking placebo as the control, to evaluate the randomized, double-blind, double-blind, randomized, double-blind, randomized, double-blind, randomized, double-blind, evaluation of the early intervention of Qingjie Xuantou Feiwei Recipe (Yinhua Pinggan Granules) in the early and mid-stage of community-acquired drug-resistant bacterial pneumonia

Phase 4
Recruiting
Conditions
Bacterial pneumonia
Registration Number
ITMCTR2100004958
Lead Sponsor
Hangzhou First People's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the diagnostic criteria for community-acquired pneumonia;
2. TCM syndrome differentiation is the syndrome of evil-stagnation lung health or phlegm-heat obstructing the lung syndrome (pneumonia is mild and moderate, the syndrome belongs to Wei-Qifen syndrome);
3. Voluntarily participate, understand and sign the informed consent;
4. Aged 18 to 85 years.

Exclusion Criteria

1. Cannot follow the treatment;
2. Patients with severe heart and brain diseases;
3. Those who are allergic to western medicine and traditional Chinese medicine;
4. Have used traditional Chinese medicine to treat patients;
5. Multi-drug resistant persons.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.